Literature DB >> 1734288

Clinical and EEG features of status epilepticus in comatose patients.

D H Lowenstein1, M J Aminoff.   

Abstract

We retrospectively evaluated the clinical and EEG features of status epilepticus (SE) in 47 comatose adult patients in whom SE was suspected clinically or because the EEG revealed repetitive electrographic seizures or continuous spike-and-wave activity. Three groups of patients were identified. Group-1 patients (n = 33) had SE both clinically and on EEG. They usually had subtle, clonic movements restricted to the eyes, face, and upper extremities, and the EEG most commonly showed repetitive electrographic seizures or continuous spike-and-wave activity. Group-2 patients (n = 9) also had subtle motor manifestations of seizures, but the EEG was not that of SE, consisting of either irregular slowing with frequent spikes and sharp waves, an irregular mixed-frequency background with episodic accentuation, or diffuse slowing; one patient also had an intermittent burst-suppression pattern. The five patients in Group 3 lacked any clinical signs of seizures, but the EEG showed repetitive electrographic seizures or continuous spike-and-wave activity. There were no significant differences between groups in etiology of SE, response to therapy, or outcome, and there was no obvious relationship between the EEG findings and duration of SE. We conclude that recognition of SE in comatose patients may require both clinical and EEG evaluation since either approach by itself may fail to establish the diagnosis. Furthermore, the EEG findings in established SE do not necessarily progress through the series of defined stages suggested by some authors.

Entities:  

Mesh:

Year:  1992        PMID: 1734288     DOI: 10.1212/wnl.42.1.100

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  13 in total

1.  Continuous or emergent EEG: can bedside caregivers recognize epileptiform discharges?

Authors:  Enrique C Leira; Mary E Bertrand; R Edward Hogan; Salvador Cruz-Flores; Kathleen W Wyrwich; Osamah J Albaker; Eve M Holzemer
Journal:  Intensive Care Med       Date:  2003-11-13       Impact factor: 17.440

Review 2.  Continuous EEG monitoring in the intensive care unit.

Authors:  Jeffrey D Kennedy; Elizabeth E Gerard
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

Review 3.  Refractory generalised convulsive status epilepticus : a guide to treatment.

Authors:  Reetta Kälviäinen; Kai Eriksson; Ilkka Parviainen
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

4.  Diagnostic yield of electroencephalography in the medical and surgical intensive care unit.

Authors:  Hooman Kamel; John P Betjemann; Babak B Navi; Manu Hegde; Karl Meisel; Vanja C Douglas; S Andrew Josephson
Journal:  Neurocrit Care       Date:  2013-12       Impact factor: 3.210

Review 5.  Diagnosis and treatment of nonconvulsive status epilepticus.

Authors:  M C Walker
Journal:  CNS Drugs       Date:  2001       Impact factor: 5.749

Review 6.  Treatment of Refractory and Super-refractory Status Epilepticus.

Authors:  Samhitha Rai; Frank W Drislane
Journal:  Neurotherapeutics       Date:  2018-07       Impact factor: 7.620

7.  Recovery from vegetative state of patients with a severe brain injury: a 4-year real-practice prospective cohort study.

Authors:  Alessio Baricich; A de Sire; E Antoniono; F Gozzerino; G Lamberti; C Cisari; M Invernizzi
Journal:  Funct Neurol       Date:  2017 Jul/Sep

8.  Nonconvulsive status epilepticus: a diagnostic and therapeutic challenge in the intensive care setting.

Authors:  Martin Holtkamp; Hartmut Meierkord
Journal:  Ther Adv Neurol Disord       Date:  2011-05       Impact factor: 6.570

9.  Non-convulsive status epilepticus: usefulness of clinical features in selecting patients for urgent EEG.

Authors:  A M Husain; G J Horn; M P Jacobson
Journal:  J Neurol Neurosurg Psychiatry       Date:  2003-02       Impact factor: 10.154

Review 10.  Electrophysiologic monitoring in acute brain injury.

Authors:  Jan Claassen; Paul Vespa
Journal:  Neurocrit Care       Date:  2014-12       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.